Definitive Healthcare Corp

CEO Kevin Coop’s March 2026 sale of 175,524 shares shows a tax‑driven, routine move that left him still holding 5 M+ shares—an insider stance that balances modest volatility and bullish leadership buying amid a competitive health‑analytics market.

Insider selling of Definitive Healthcare shares raises doubts about the firm’s near‑term outlook—learn what this pattern signals for investors and when to watch next.